Sarcomas in children with neurofibromatosis type 1 - Poor prognosis despite aggressive combined therapy in four patients treated in a single oncological institution
Child's Nervous System, ISSN: 0256-7040, Vol: 23, Issue: 10, Page: 1147-1153
2007
- 13Citations
- 31Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations13
- Citation Indexes12
- 12
- CrossRef11
- Policy Citations1
- Policy Citation1
- Captures31
- Readers31
- 31
Article Description
Objects: Patients with neurofibromatosis type 1 (NF1) are predisposed to developing soft tissue sarcomas (STS). Materials and methods: We report on four cases of STS diagnosed in locally advanced, unresectable stages in children with NF1 (three girls, one boy; age = 8 months 14 years). All patients received protocols for STS: Cooperative Weichteilsarkomstudie 91, 96 and 2002. One patient with limb rhabdomyosarcoma entered complete remission but developed late metastatic relapse and died of progression despite complete excision and autologous bone marrow transplantation. The other patient with bladder rhabdomyosarcoma died of neutropenia-related sepsis without remission. Patients with malignant peripheral nerve sheet tumour and malignant triton tumour located in the pelvis did not respond to therapy. One of them died of disease progression, while the other is disease-free 6 years post-therapy after mutilating tumour resection. Conclusion: STS in NF1 seem to display poor prognosis in spite of combined therapy; thus, children with NF1 should remain under detailed control of the oncologist. © Springer-Verlag 2007.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=34548610966&origin=inward; http://dx.doi.org/10.1007/s00381-007-0392-8; http://www.ncbi.nlm.nih.gov/pubmed/17628808; http://link.springer.com/10.1007/s00381-007-0392-8; https://dx.doi.org/10.1007/s00381-007-0392-8; https://link.springer.com/article/10.1007/s00381-007-0392-8; http://www.springerlink.com/index/10.1007/s00381-007-0392-8; http://www.springerlink.com/index/pdf/10.1007/s00381-007-0392-8
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know